No takes yet. Share an insight, caveat, or question.
Highlights how baseline risk influences trial design and the interpretation of absolute versus relative risk reduction in HFrEF.
Spall et al. (2021) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: